NEYPPC Pharmacy - Unlicensed Imported Medicines (Wave 1)
In plain English
The notice doesn't say
Who holds it now
Last won by Clinigen Healthcare Limited and Mawdsley-Brooks & Co Ltd and Durbin PLC and 4 more in Mar 2026, for £27.4m.
- NEYPPC Pharmacy - Unlicensed Imported Medicines 2025Clinigen Healthcare Limited, Mawdsley-Brooks & Co Ltd, Durbin PLC and 4 more £27.4m
- Framework Agreement for the Supply of Unlicensed Imported Medicines Services and Products to Trusts within the North of England with the inclusion of mini competitions and/or direct awards.Target Healthcare Ltd, Eaststone Ltd, Alium Medical Ltd and 4 more £15.4m
What you're up against
- The same firms have won it the last 2 times Kestrel found: expect them to bid again, and to know the work well.
- 8 different firms won this buyer's 2 awards for this kind of work in 2026.
- It last went for £27.4m in 2026.
- The last award named 7 suppliers: it may be a framework, where many firms are chosen.
The notice as published
The North East and Yorkshire NHS Pharmaceutical Purchasing Consortium intends to run a further competition under its established Dynamic Market for the supply of Unlicensed Imported Medicines. This route enables flexible, efficient and sustainable sourcing by drawing on a continuously open pool of qualified suppliers. The requirement will cover the provision of unlicensed medicines imported from trusted countries and must fully comply with all applicable UK regulatory standards. Participating suppliers will be required to hold the appropriate import and wholesale licenses, together with all other permissions necessary to supply unlicensed medicines within the UK. Using the established Dynamic Market ensures that NHS Trusts across the region can access safe, compliant, and competitively sourced unlicensed medicines, supporting resilient supply chains and maintaining strong assurance of product quality.